In plain English
ARK Genomic Revolution ETF (ARKG) tracks companies that are developing or using genomics and precision‑medicine technologies, including…
Fund that tracks a market or index · NYSE Arca · USD
ARKG
ARK Genomic Revolution ETF
$48.16
Today
+$0.29+0.61%
vs yesterday’s close
Live price
- Opened at
- $47.52
- Day high
- $48.21
- Day low
- $46.68
- Yesterday’s close
- $47.87
- Sector
- ETF
- Size
- Fund
- Exchange
- NYSE Arca
Price chart Pro
Loading chart…
Loading chart…
Company briefing
What ARKG is
Plain English context — why the name shows up in the news, and what to watch next.
Latest on this name
Insights & deeper context
2 recent cards — open any for the full deeper dive.
Next Biotech Boom May Be Cancer Vaccines: Watch These ETFs
In brief
Positive Phase 3 results for a personalized mRNA cancer vaccine could ignite a new biotech boom beyond obesity drugs, boosting genomics and precision‑medicine ETFs.
Merck, Moderna Cancer Vaccine Breakthrough Could Be Catalyst the mRNA ETF Trade Has Been Waiting For
In brief
The first positive Phase 3 mRNA cancer trial may revive the mRNA investment thesis beyond COVID and boost precision‑medicine ETFs.
Company reports
Official filings (US SEC and linked cards)
No filings here yet
Official report cards for ARKG will show up here when available.
Broad market indexes (like the S&P 500, a basket of 500 large US companies) are shown through popular funds that track them (for example SPY). Company profile and prices use live market data when available.